Investing.com - Thorne HealthTech (NASDAQ: THRN) reported first quarter EPS of $0.06, $0.01 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $65.2M versus the consensus estimate of $66.2M.
Guidance
Thorne HealthTech sees FY 2023 EPS of $0.25-$0.31 versus the analyst consensus of $0.32.
Thorne HealthTech sees FY 2023 revenue of $280.00M-$290.00M versus the analyst consensus of $283.30M.
Thorne HealthTech's stock price closed at $4.64. It is up 8.92% in the last 3 months and down -29.38% in the last 12 months.
Thorne HealthTech saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Thorne HealthTech's stock price’s past reactions to earnings here.
According to InvestingPro, Thorne HealthTech's Financial Health score is "good performance".
Check out Thorne HealthTech's recent earnings performance, and Thorne HealthTech's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar